Pharmacodynamics of 750 mg and 500 mg doses of levofloxacin against ciprofloxacin-resistant strains of Streptococcus pneumoniae

This publication has 23 references indexed in Scilit:

• Decreased Susceptibility ofStreptococcus pneumoniaeto Fluoroquinolones in Canada
  New England Journal of Medicine, 1999
• The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada—1997 results from the SENTRY Antimicrobial Surveillance Program
  Diagnostic Microbiology and Infectious Disease, 1998
• Double-Blind Evaluation of the Safety and Pharmacokinetics of Multiple Oral Once-Daily 750-Milligram and 1-Gram Doses of Levofloxacin in Healthy Volunteers
  Antimicrobial Agents and Chemotherapy, 1998
• Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA
  Diagnostic Microbiology and Infectious Disease, 1997
• Comparison of the antibacterial activities of the quinolones Bay 12- 8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin [published erratum appears in J Antimicrob Chemother 1998 Jun;41(6):672]
  Journal of Antimicrobial Chemotherapy, 1997
• In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
  Antimicrobial Agents and Chemotherapy, 1997
• The post-antibiotic sub-MIC effect in vitro and in vivo
  Journal of Antimicrobial Chemotherapy, 1993
• First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use
  Antimicrobial Agents and Chemotherapy, 1991
• Adaptive Resistance to Aminoglycoside Antibiotics from First-Exposure Down-Regulation
  The Journal of Infectious Diseases, 1990
• Two compartment kinetic model with multiple artificial capillary units
  Journal of Antimicrobial Chemotherapy, 1985